Rocket Pharmaceuticals (RCKT) News Today $10.31 +0.10 (+0.98%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week Low - Should You Sell?Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low - Here's WhyJanuary 17 at 5:20 AM | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4% - Here's What HappenedJanuary 16, 2025 | marketbeat.comMirador Capital Partners LP Buys 67,755 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Mirador Capital Partners LP grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 403.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 84,529 shares of the biotechnology company's stock after purchasing an addiJanuary 16, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 12-Month Low - Time to Sell?January 10, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.9% - Time to Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 6.9% - Time to Buy?January 7, 2025 | marketbeat.comBuy Recommendation for Rocket Pharmaceuticals: Promising Potential of RP-L301 in Severe PKD CasesJanuary 7, 2025 | markets.businessinsider.comRocket Pharmaceuticals (RCKT) Gets a Buy from Bank of America SecuritiesJanuary 6, 2025 | markets.businessinsider.comRocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | finance.yahoo.comRocket Pharmaceuticals Inc RCKTJanuary 1, 2025 | morningstar.comBrokers Set Expectations for RCKT Q4 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Analysts at Wedbush issued their Q4 2024 EPS estimates for shares of Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, December 30th. Wedbush analyst Y. Zhong forecasts that the biotechnology company wJanuary 1, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 3.7% - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 3.7% - Should You Buy?December 31, 2024 | marketbeat.comPromising Pipeline and Strategic Developments Propel Rocket Pharmaceuticals to ‘Buy’ RatingDecember 31, 2024 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by WedbushWedbush initiated coverage on shares of Rocket Pharmaceuticals in a report on Monday. They set an "outperform" rating and a $32.00 price objective for the company.December 30, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | msn.comRocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | insidermonkey.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by AnalystsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) has received an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and ten have assigned a buy recoDecember 29, 2024 | marketbeat.comSpotlight on Rocket Lab USA: Analyzing the Surge in Options ActivityDecember 26, 2024 | benzinga.comFederal watchdog sues Rocket Companies' subsidiary for alleged kickbacksDecember 23, 2024 | msn.comEvercore ISI Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)December 23, 2024 | markets.businessinsider.comRocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growthDecember 23, 2024 | uk.investing.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year Low - Time to Sell?December 19, 2024 | marketbeat.comFranklin Resources Inc. Reduces Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Franklin Resources Inc. decreased its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 7.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,730,344 shares of the biotechnology company's stock after selling 143,345 shares during tDecember 19, 2024 | marketbeat.comState Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)State Street Corp lifted its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 11.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,102,022 shares of the biotechnology company's stock after pDecember 19, 2024 | marketbeat.comJefferies Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Buy RecommendationDecember 18, 2024 | msn.comRocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'December 18, 2024 | investopedia.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Still a Buy?December 18, 2024 | marketbeat.comJefferies Financial Group Initiates Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)Jefferies Financial Group started coverage on shares of Rocket Pharmaceuticals in a report on Wednesday. They set a "buy" rating and a $29.00 price objective for the company.December 18, 2024 | marketbeat.comSynovus Financial Corp Trims Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Synovus Financial Corp reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 43.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,504 shares of the biotechnolDecember 16, 2024 | marketbeat.comFY2024 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Stock analysts at Leerink Partnrs upped their FY2024 EPS estimates for shares of Rocket Pharmaceuticals in a report issued on Wednesday, December 11th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company willDecember 16, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week Low - Time to Sell?December 13, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Fmr LLCFmr LLC lessened its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 19.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 465,456 shares of the biotechnology company's stock after selling 113,823 shares during the quarter. FmDecember 12, 2024 | marketbeat.comRocket Pharmaceuticals 13.2M share Spot Secondary priced at $12.50December 11, 2024 | markets.businessinsider.comPoint72 Asset Management L.P. Invests $888,000 in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Point72 Asset Management L.P. purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 48,096 shares of the biotechnology company's stDecember 11, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Lowers Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Frazier Life Sciences Management L.P. cut its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,485,630 sharDecember 10, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,242,December 9, 2024 | marketbeat.comJanus Henderson Group PLC Has $35.06 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Janus Henderson Group PLC decreased its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 35.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,897,340 shares of the biotechnology company'sDecember 7, 2024 | marketbeat.comErste Asset Management GmbH Purchases New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Erste Asset Management GmbH purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 44,700 shares of the biotechnology company's stock, valued at approximaDecember 4, 2024 | marketbeat.comWalleye Capital LLC Acquires Shares of 138,403 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Walleye Capital LLC acquired a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 138,403 shares of the biotechnology company's stock, valued at approximately $2,556,000. WallDecember 4, 2024 | marketbeat.comBamco Inc. NY Reduces Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Bamco Inc. NY lessened its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 9.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 884,341 shares of the biotechnology company's stock after selling 94,990 shDecember 3, 2024 | marketbeat.comRocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks RemainDecember 2, 2024 | seekingalpha.comAcuta Capital Partners LLC Sells 60,370 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Acuta Capital Partners LLC reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 24.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 190,000 shares of the biotechnology comNovember 28, 2024 | marketbeat.com3 Small-Cap Stocks That Are Ready to Rocket Higher (RCKT)With lower interest rates and lower corporate taxes more likely, it's a good time to consider three small-cap stocks that present a buying opportunityNovember 27, 2024 | marketbeat.comRocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx ConferenceNovember 26, 2024 | businesswire.comMartin Wilson Sells 1,175 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) StockNovember 26, 2024 | insidertrades.comWestfield Capital Management Co. LP Grows Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Westfield Capital Management Co. LP boosted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 3.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,493,833 shares of the biotechnNovember 24, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.3% - Time to Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 6.3% Higher - Should You Buy?November 22, 2024 | marketbeat.comFY2025 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2025 earnings estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Monday, November 18th. Leerink Partnrs analyst M. Foroohar now anticipates that tNovember 21, 2024 | marketbeat.comRocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: AnalystNovember 19, 2024 | benzinga.comPromising Clinical Developments in Rocket Pharmaceuticals Justify Buy Rating and $52 Target PriceNovember 19, 2024 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)November 19, 2024 | markets.businessinsider.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.230.44▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼36▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APLS News Today RARE News Today VKTX News Today ACLX News Today IMVT News Today CRNX News Today RNA News Today PTCT News Today RYTM News Today DNLI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts